Short Interest in Dominari Holdings Inc. (NASDAQ:DOMH) Rises By 396.4%

Dominari Holdings Inc. (NASDAQ:DOMH) was the target of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 41,200 shares, an increase of 396.4% from the December 31st total of 8,300 shares. Based on an average daily volume of 27,200 shares, the days-to-cover ratio is presently 1.5 days. Approximately 1.2% of the company’s shares are short sold.

Dominari Stock Performance

Shares of DOMH stock traded up $0.16 during mid-day trading on Thursday, hitting $2.43. The company’s stock had a trading volume of 91,096 shares, compared to its average volume of 130,101. The stock has a market cap of $15.41 million, a price-to-earnings ratio of -0.63 and a beta of 1.03. The business has a 50-day moving average price of $1.41 and a 200 day moving average price of $1.63. Dominari has a 52-week low of $0.83 and a 52-week high of $3.20.

Dominari (NASDAQ:DOMH) last posted its earnings results on Friday, November 8th. The company reported ($0.45) earnings per share for the quarter. The business had revenue of $4.04 million during the quarter. Dominari had a negative return on equity of 32.89% and a negative net margin of 180.22%.

Dominari Company Profile

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.